--- title: "Weixing: Net profit in the third quarter was 214 million yuan, a year-on-year increase of 3.03%" type: "News" locale: "en" url: "https://longbridge.com/en/news/263064495.md" description: "Weixing announced that the revenue for the third quarter was 1.295 billion yuan, a year-on-year increase of 0.86%; the net profit was 214 million yuan, a year-on-year increase of 3.03%. The revenue for the first three quarters was 3.633 billion yuan, a year-on-year increase of 1.46%; the net profit was 583 million yuan, a year-on-year decrease of 6.46%" datetime: "2025-10-28T10:58:52.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/263064495.md) - [en](https://longbridge.com/en/news/263064495.md) - [zh-HK](https://longbridge.com/zh-HK/news/263064495.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/263064495.md) | [繁體中文](https://longbridge.com/zh-HK/news/263064495.md) # Weixing: Net profit in the third quarter was 214 million yuan, a year-on-year increase of 3.03% Weixing announced that its revenue for the third quarter was 1.295 billion yuan, a year-on-year increase of 0.86%; net profit was 214 million yuan, a year-on-year increase of 3.03%. Revenue for the first three quarters was 3.633 billion yuan, a year-on-year increase of 1.46%; net profit was 583 million yuan, a year-on-year decrease of 6.46% ### Related Stocks - [Weixing (002003.CN)](https://longbridge.com/en/quote/002003.CN.md) ## Related News & Research - [Taiwan February exports +20.6% y/y, below forecasts](https://longbridge.com/en/news/278353139.md) - [BYD weighs Canada plant, legacy automaker buyout amid global push](https://longbridge.com/en/news/278974771.md) - [Fosun Pharma Unit Gets China Nod for Hematological Malignancy Drug Trial](https://longbridge.com/en/news/279052280.md) - [Xprize founder Peter Diamandis launches new contest to manifest a new Star Trek](https://longbridge.com/en/news/278419951.md) - [BYD reportedly explores F1 entry to boost global brand appeal](https://longbridge.com/en/news/278576491.md)